Page 1 of Clinical Trials for Drug busulfan, 374 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Not yet recruiting
Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation
Last Updated: May 9, 2012
Condition(s): Myeloid Malignancy; Bone Marrow Failure Syndrome; Transfusion-dependent Red Blood Cell (RBC) Defect; Congenital Immunodeficiency; Metabolic Disease; Severe Immune Dysregulation
2
Active, not recruiting
Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant
Last Updated: July 15, 2011
Condition(s): Myelodysplastic and Myeloproliferative Disorders; Acute Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Chronic Myelogenous Leukemia; Multiple Myeloma; Plasma Cell Dyscrasia; Lymphoproliferative Disorders; Hematologic Diseases
3
Completed
Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor
Last Updated: July 9, 2009
Condition(s): Leukemia; Myelodysplastic Syndrome; Non-Hodgkin's Lymphoma; Allogeneic Marrow Transplant
4
Completed
Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant
Last Updated: April 7, 2010
Condition(s): Granulomatous Disease; Chronic
5
Recruiting
Umbilical Cord Blood Transplant for Children With Myeloid Hematological Malignancies
Last Updated: August 12, 2011
Condition(s): Congenital Pediatric Disorders
6
Recruiting
Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions
Last Updated: January 31, 2012
Condition(s): Multiple Myeloma
7
Terminated
Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer
Last Updated: July 19, 2011
Condition(s): Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Unusual Cancers of Childhood
8
Recruiting
Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy
Last Updated: January 25, 2012
Condition(s): MDS; Leukemias; Lymphomas
9
Active, not recruiting
Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma
Last Updated: January 17, 2012
Condition(s): CNS Lymphoma; CNS Brain Cancer; Non-Hodgkin's Lymphoma
10
Completed
IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency
Last Updated: June 29, 2009
Condition(s): T-Cell Immune Deficiency Diseases; Severe Combined Immunodeficiency
11
Recruiting
Donor Stem Cell Transplantation for Congenital Immunodeficiencies
Last Updated: April 26, 2012
Condition(s): MUD Transplant; AlloPBSC; Congenital Immunodeficiencies; HLA Matched Transplant; BMT
12
Completed
Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma
Last Updated: December 15, 2011
Condition(s): Multiple Myeloma; Lymphoma
13
Recruiting
Matched Unrelated or Non-Genotype Identical Related Donor Transplantation For Chronic Granulomatous Disease
Last Updated: May 18, 2012
Condition(s): Chronic Granulomatous Disease
14
Terminated
UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma Patients
Last Updated: June 20, 2011
Condition(s): Multiple Myeloma
15
Active, not recruiting
Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen
Last Updated: November 17, 2011
Condition(s): Leukemia; Hodgkin Lymphoma; Non-Hodgkin Lymphoma; Multiple Myeloma; Myelodysplastic Syndrome
16
Recruiting
Fludarabine, Busulfan, and Alemtuzumab Followed By Donor Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disease
Last Updated: February 16, 2012
Condition(s): Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Precancerous Condition
17
Completed
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia
Last Updated: October 26, 2010
Condition(s): Leukemia
18
Active, not recruiting
Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia
Last Updated: February 6, 2009
Condition(s): Leukemia
19
Completed
Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Last Updated: February 16, 2011
Condition(s): Leukemia; Myelodysplastic Syndromes; Myelodysplastic-Myeloproliferative Diseases
20
Recruiting
Umbilical Cord Blood Transplant for Congenital Pediatric Disorders
Last Updated: August 12, 2011
Condition(s): Congenital Pediatric Disorders

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+busulfan

Page 1 of Clinical Trials for Drug busulfan, 374 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About